Syntonix Pharmaceuticals, Inc.

Syntonix is developing next generation biopharmaceuticals that enable better treatment options for patients with devastating chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company applies its core technologies to develop long-acting biopharmaceuticals that may be inhaled or injected less frequently, and to discover novel drugs to treat antibody-mediated autoimmune and inflammatory disorders. The resulting proteins, peptides and antibodies are being commercialized through internal development programs and collaborations with biotechnology and pharmaceutical partners. The company’s lead product is a long-acting Factor IX product for the treatment of Hemophilia B, which is being developed in a strategic alliance with Biovitrum AB of Sweden. Upon approval, Syntonix will market the product in North America.

Contact Details: 9 Fourth Avenue Waltham Massachusetts 02451 United States of America Tel: 781.547.6000 Fax: 781.547.6008 Email: generalinformation@syntnx.com WWW: www.syntnx.com/

Loading...

BioNews Results for Syntonix Pharmaceuticals, Inc.:
ACADIA Pharmaceuticals Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 7:49AM Matching: pharmaceuticals inc
Adherex Technologies Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 7:07AM Matching: pharmaceuticals inc
Achillion Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 7:22AM Matching: pharmaceuticals inc
Angiotech Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report	PR inside:  Nov 16 2009 5:28AM Matching: pharmaceuticals inc
AngioDynamics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released	PR inside:  Nov 16 2009 5:28AM Matching: pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Syntonix Pharmaceuticals, Inc. news.

Syntonix Pharmaceuticals, Inc. Patents:
US Patent No.	Title
7566565	PC5 as a factor IX propeptide processing enzyme
7404956	Immunoglobulin chimeric monomer-dimer hybrids
7381408	Methods for chemically synthesizing immunoglobulin chimeric proteins
7348004	Immunoglobulin chimeric monomer-dimer hybrids

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 491 times since April 2007, the link to the organisation's website has been followed 61 times

Recent Search Terms used to find this page: syntonix pharmaceuticals patents | syntonix | Syntonix Pharmaceuticals | Syntonix Pharmaceuticals press release antibody | syntonix pharmaceuticals | Syntonix | syntonix pharmaceuticals | syntonix | .

Search for more companies in Waltham

Search for more companies in Massachusetts

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Syntonix Pharmaceuticals, Inc.